<PAGE>
[PHOTO OF TEB BUTZ] Ted Butz
General Manager,
FMC BioPolymer
<PAGE>
Specialty Chemicals
2000 Forecast
[PIE CHART]
Food & Transportation
21%
Industrial
Chemicals
20%
Specialty
Chemicals
13%
$500M
Agricultural
Products
18%
Energy Systems
28%
Total FMC Sales = $3.9 Billion
<PAGE>
Specialty Chemicals
2000 Overview
Sales [PIE CHART] Key Markets [PIE CHART]
BioPolymer Lithium Pharmaceutical Approximately 1/3
Approximately 2/3 Approximately 1/3 Food Ingredients Approximately 1/3
Specialty Approximately 1/3
Total Specialty Chemical Sales = $500 Million
FMC
<PAGE>
Specialty Chemicals
Segment Sales ($M)
[Bar graph A]
750
602.0 604.8 598.2
564.5
500 --
250
0
1996 1997 1998 1999 2000 Fcst
Segment EBIT ($M)
[Bar graph B]
100
--
80
77.9
77.2
73.5
65.5
60
40
20
0
1996 1997 1998 1999 2000 Fcst
<PAGE>
Positioned for growth:
Consolidating and Strengthening in 1999
1. Divested businesses that lacked long-term growth potential
2. Reduced production of commodity lithium carbonate
3. Focused resources on high margin products
4. Acquired & integrated Pronova BioPolymer with FMC's food ingredients and
pharmaceutical businesses
<PAGE>
Specialty Chemicals
Segment Margins
Year Results
---- -------
2000 17.5%
(forecast)
1999 13.0%
1998 13.0%
1997 12.9%
<PAGE>
Specialty Chemicals
Opportunities and Outlook
- FMC BioPolymer
- FMC Lithium
<PAGE>
FMC BioPolymer Was Created In
1999
FMC BioPolymer
Not Just Products. Partners.
<PAGE>
Leading Products Serving A Global
Market
[PIE CHART 1] [PIE CHART 2]
Algin ROW
19% 17%
CGN North Am
37% 47%
Other Europe
8% 36%
MCC
36%
<PAGE>
Leading Pharmaceutical,
Food, & Specialty Customers
- Abbot Labs - Mars
- American Home - Merck
- Bristol Myers - Mylan
- Brahma - Nestle
- Colgate - Novartis
- ConAgra - Pharmacia
- CPC - Pfizer
- Danisco - Reckitt Coleman
- General Mills - San Ei
- Glaxo - SlimFast
- Goodman Fielder - SmithKline
- Johnson & Johnson - Unilever
- Kraft Foods
<PAGE>
FMC BioPolymer Consists of
Three Attractive Businesses
Business Total Growth
-------- Sales Prospects
----- ---------
Pharmaceuticals 37% 5-6%
Food Ingredients 42% 4-6%
Specialty 21% 2-10%
FMC
<PAGE>
Pharmaceutical Opportunities
CORE PRODUCTS NEW SEGMENTS
------------- ------------
- MCC - EnTec(SM) Drug Delivery
- ALGINATES - Wound Care / Immunostimulants
- COATINGS AND HYDROCOLLOIDS - Medical Materials
- Taste-masking
- Other Services
CORE GROWTH [PHOTO OF PHARMACEUTICALS APPEARS HERE]
-----------
- Nutraceuticals
- Coatings
- Other Anti-reflux
- Acquisition
- Coatings
FMC
<PAGE>
Pharmaceutical Opportunities
- Core growth
- Alginates used for anti- [PHOTO OF ALIGNATES IN ACTION APPEARS HERE]
reflux treatment
- New segment growth [PHOTO OF PROTANAL(R) IN USE APPEARS HERE]
- Protanal(R) for use in
advanced wound dressing
<PAGE>
Food Ingredients Opportunities
CORE PRODUCTS NEW TRENDS
------------- ----------
- MCC - Taste
- CARRAGEENAN - Nutrition
- ALGINATES - Convenience
- Niche applications
CORE GROWTH
----------- [PHOTO OF FOOD APPEARS HERE]
- Dairy
- Convenience foods
- Meat and poultry
- Bakery and confection
FMC
<PAGE>
Food Ingredients Opportunities
- Taste, nutrition and convenience
- Cultured products, such as yogurt
- Nutritional beverages
- Other nutritional applications
FMC
<PAGE>
Specialty Opportunities
- Oral care
- Personal care
- Laundry and dishwasher tablets
- Niche industrial applications
<PAGE>
FMC BioPolymer
Not Just Products. Partners.
- Strong core business
- Earnings on track
- Focused on higher margin segments
- Strong growth potential
<PAGE>
--------------------------------------------------------------------------------
FMC Lithium
. Lithium and lithium derived products
. Manufacturing facilities in 4 countries
. 52% of sales outside of US
[PHOTO APPEARS HERE]
--------------------------------------------------------------------------------
<PAGE>
Lithium Markets
Total
Business Focus Sales
-------------- -----
Downstream applications 75%
Pharmaceuticals, energy and
specialty polymers
Upstream applications 25%
Refrigeration, rubber treatment
Overall CGR of 7%
FMC
<PAGE>
FMC Lithium Strategy
- Focused resources on downstream specialty opportunities
- Outsourced production of most commodity lithium carbonate requirements
- Maintain manufacturing cost position of high-value lithium
- Increased technical resources to help customers speed product development
FMC
<PAGE>
FMC Lithium Opportunities
- Lifetime(R) and Renew(R) ASR [PHOTO OF LITHIUM BATTERIES APPEARS HERE]
concrete technologies
- Pharmaceutical, Agricultural, [PHOTO OF A PHARMACIST APPEARS HERE]
and specialty polymers.
- Lithium ion batteries [PHOTO OF A CONCRETE SURFACE APPEARS HERE]
FMC
<PAGE>
FMC Lithium Opportunities
- Electric and hybrid
electric vehicles
[PHOTO OF ELECTRIC/HYBRID ELECTRIC VEHICLE
APPEARS HERE]
- Available by 2005
- Consortium headed by
Argonne National Labs
(US DOE) [PHOTO OF ELECTRIC/HYBRID ELECTRIC VEHICLE
APPEARS HERE]
- Lithium ion batteries are
key to this opportunity
FMC
<PAGE>
FMC
Specialty Chemicals Panel
Joseph H. Netherland President
FMC Corporation
Ted Butz General Manager
FMC BioPolymer
D. Michael Wilson General Manager
Lithium
